European Microbiome Leaders Panel Discussion

Time: 8:05 am
day: Day One


  • What are the recent failures and setbacks surrounding clinical research?
  • What has been learnt from this?
  • What are the most prominent developments disrupting the field in the last 12 months?
  • Are there any approaches and technologies that are leading these positive developments
  • Therefore, where are the opportunities lying?
  • To summarise, what do you see as the best strategy to obtain a commercial product from the clinic?